Clinical evaluation of a fully automated CMV PCR assay

Journal of Clinical Virology

Volumn 50, Issue 4, 2011, Pages 281-286

  Kerschner, Heidrun ^a,d   Bauer, Claudia ^a   Schlag, Peter ^b   Lee, Sung ^b   Goedel, Sebastian ^c   Popow Kraupp, Theresia ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ROCHE MOLECULAR SYSTEMS   (United States)

^c Roche Diagnostics (Schweiz) AG   (Switzerland)

^d Apothekenleitung   (Austria)

Author keywords

Cytomegalovirus; EDTA plasma; High throughput; PCR; Viral load

Indexed keywords

EDETIC ACID; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEASIBILITY STUDY; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BIOLOGICAL ASSAY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEASIBILITY STUDIES; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES;

EID: 79952624971     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.12.010     Document Type: Article

References (30)

1. Emery V.C., Sabin C.A., Cope A.V., Gor D., Hassan-Walker A.F., Griffiths P.D. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000, 355(9220 (June 10)):2032-2036.
2. Humar A., Kumar D., Boivin G., Caliendo A.M. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease. J Infect Dis 2002, 186(6 (September 15)):829-833.
3. Sia I.G., Wilson J.A., Groettum C.M., Espy M.J., Smith T.F., Paya C.V. Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation. J Infect Dis 2000, 181(2 (February)):717-720.
4. Ghisetti V., Barbui A., Franchello A., Varetto S., Pittaluga F., Bobbio M., et al. Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation. J Med Virol 2004, 73(2 (June)):223-229.
5. Piiparinen H., Helantera I., Lappalainen M., Suni J., Koskinen P., Gronhagen-Riska C., et al. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients. J Med Virol 2005, 76(3 (July)):367-372.
6. Martin-Davila P., Fortun J., Gutierrez C., Marti-Belda P., Candelas A., Honrubia A., et al. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value. J Clin Virol 2005, 33(2 (June)):138-144.
7. Lehto J.T., Lemstrom K., Halme M., Lappalainen M., Lommi J., Sipponen J., et al. A prospective study comparing cytomegalovirus antigenemia DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients. Transpl Int 2005, 18(12 (December)):1318-1327.
8. Westall G.P., Michaelides A., Williams T.J., Snell G.I., Kotsimbos T.C. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients. J Infect Dis 2004, 190(6 (September 15)):1076-1083.
9. Sia I.G., Wilson J.A., Espy M.J., Paya C.V., Smith T.F. Evaluation of the COBAS AMPLICOR CMV MONITOR test for detection of viral DNA in specimens taken from patients after liver transplantation. J Clin Microbiol 2000, 38(2 (February)):600-606.
10. Pas S., Rossen J.W., Schoener D., Thamke D., Pettersson A., Babiel R., et al. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA. J Clin Microbiol 2010, 48(4 (April)):1195-1200.
11. Chevaliez S., Pawlotsky J.M. How to use virological tools for optimal management of chronic hepatitis C. Liver Int 2009, 29(Suppl 1 (January)):9-14.
12. Chevaliez S., Bouvier-Alias M., Laperche S., Pawlotsky J.M. Performance of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification. J Clin Microbiol 2008, 46(5 (May)):1716-1723.
13. Tholen D., Kroll M., Astles J.R. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline 2003, vol. 23(16). Clinical and Laboratory Standards Institute, EP6-A.
14. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1(8476 (February 8)):307-310.
15. Gleaves C.A., Welle J., Campbell M., Elbeik T., Ng V., Taylor P.E., et al. Multicenter evaluation of the Bayer VERSANT HIV-1 RNA 3.0 assay: analytical and clinical performance. J Clin Virol 2002, 25(2 (August)):205-216.
16. Michelin B.D., Hadzisejdic I., Bozic M., Grahovac M., Hess M., Grahovac B., et al. Detection of cytomegalovirus (CMV) DNA in EDTA whole-blood samples: evaluation of the quantitative artus CMV LightCycler PCR kit in conjunction with automated sample preparation. J Clin Microbiol 2008, 46(4 (April)):1241-1245.
17. Caliendo A.M., Ingersoll J., Fox-Canale A.M., Pargman S., Bythwood T., Hayden M.K., et al. Evaluation of real-time PCR laboratory-developed tests using analyte-specific reagents for cytomegalovirus quantification. J Clin Microbiol 2007, 45(6 (June)):1723-1727.
18. Raggam R.B., Bozic M., Salzer H.J., Hammerschmidt S., Homberg C., Ruzicka K., et al. Rapid quantitation of cytomegalovirus DNA in whole blood by a new molecular assay based on automated sample preparation and real-time PCR. Med Microbiol Immunol 2010, 199(4 (November)):311-316.
19. Chen G., Kobayashi L., Nazarenko I. Effect of sample aliquot size on the limit of detection and reproducibility of clinical assays. Clin Chem 2007, 53(11 (November)):1962-1965.
20. Gracia-Ahufinger I., Tormo N., Espigado I., Solano C., Urbano-Ispizua A., Clari M.A., et al. Differences in cytomegalovirus plasma viral loads measured in allogeneic hematopoietic stem cell transplant recipients using two commercial real-time PCR assays. J Clin Virol 2010, 48(2 (June)):142-146.
21. Ljungman P., de la Camara R., Cordonnier C., Einsele H., Engelhard D., Reusser P., et al. Management of CMV, HHV-6 HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant 2008, 42(4 (August)):227-240.
22. Zamora M.R., Davis R.D., Leonard C. Management of cytomegalovirus infection in lung transplant recipients: evidence-based recommendations. Transplantation 2005, 80(2 (July 27)):157-163.
23. Allice T., Enrietto M., Pittaluga F., Varetto S., Franchello A., Marchiaro G., et al. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test. J Med Virol 2006, 78(7 (July)):915-922.
24. Mengelle C., Sandres-Saune K., Pasquier C., Rostaing L., Mansuy J.M., Marty M., et al. Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay. J Clin Microbiol 2003, 41(8 (August)):3840-3845.
25. Garrigue I., Boucher S., Couzi L., Caumont A., Dromer C., Neau-Cransac M., et al. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients. J Clin Virol 2006, 36(1 (May)):72-75.
26. Razonable R.R., Brown R.A., Wilson J., Groettum C., Kremers W., Espy M., et al. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation 2002, 73(6 (March 27)):968-973.
27. Mengelle C., Legrand-Abravanel F., Mansuy J.M., Barthe C., Da Silva I., Izopet J. Comparison of two highly automated DNA extraction systems for quantifying Epstein-Barr virus in whole blood. J Clin Virol 2008, 43(3 (November)):272-276.
28. Stevens W., Erasmus L., Moloi M., Taleng T., Sarang S. Performance of a novel human immunodeficiency virus (HIV) type 1 total nucleic acid-based real-time PCR assay using whole blood and dried blood spots for diagnosis of HIV in infants. J Clin Microbiol 2008, 46(12 (December)):3941-3945.
29. Lazzarotto T., Guerra B., Lanari M., Gabrielli L., Landini M.P. New advances in the diagnosis of congenital cytomegalovirus infection. J Clin Virol 2008, 41(3 (March)):192-197.
30. Ljungman P., Griffiths P., Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002, 34(8):1094-1097.